IL21 and Lymphadenopathy: Interestingly, blockade of IL-21 has been reported to reduce the MRL-Faslpr disease, including lymphadenopathy [42], and this cytokine has been shown to support the survival and function of chronically-activated CD8+ T cells during a persistent viral infection [43].